谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

New Combination Regimens Vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers

Giulia Battaglia,Davide Lazzarotto,Ilaria Tanasi,Carmela Gurrieri, Laura Forlani,Endri Mauro, Francesca Capraro, Giulia Ciotti,Eleonora De Bellis,Chiara Callegari,Luca Tosoni, Matteo Fanin, Gian Luca Morelli, Claudia Simio,Cristina Skert,Michele Gottardi,Francesco Zaja,Eleonora Toffoletti,Daniela Damiani,Renato Fanin,Mario Tiribelli

Journal of clinical medicine（2025）

引用 0|浏览0
关键词
acute myeloid leukemia,induction therapy,midostaurin,gemtuzumab ozogamicin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要